0
Sleep Disorders |

The Efficacy of a Chinstrap in the Treatment of Obstructive Sleep Apnea

Neola Gushway-Henry, MD; Sushanth Bhat, MD; Sandeep Riar, MD; Vincent DeBari, MD; Disha Patel, MD; Justin Pi, MD; Liudmila Lysenko, MD; Divya Gupta, MD; Sudhansu Chokroverty, MD; Peter Polos, MD
Author and Funding Information

JFK Medical Center, Edison, NJ


Chest. 2013;144(4_MeetingAbstracts):993A. doi:10.1378/chest.1660290
Text Size: A A A
Published online

Abstract

SESSION TITLE: Sleep Posters

SESSION TYPE: Original Investigation Poster

PRESENTED ON: Wednesday, October 30, 2013 at 01:30 PM - 02:30 PM

PURPOSE: Vorona et al. (2007) described severe obstructive sleep apnea (OSA) responding to the use of a chinstrap alone in a patient who had stopped using a continuous positive airway pressure (CPAP) device for two months. They reported an improved apnea-hypopnea index (AHI) and oxygen saturation with chinstrap use, and suggested that chinstraps merit investigation as treatment for OSA. We performed this study to determine if a chinstrap alone was an alternative to CPAP in the treatment of OSA

METHODS: 27 adult subjects with AHIs 5/hr or greater on initial diagnostic polysomnography (PSG) were enrolled. All subjects underwent a modified split titration study (wearing a chinstrap alone for the first two hours of sleep, and titrated for the rest of the night with CPAP in the standard method without a chinstrap). We compared the general AHIs and oxygen saturation nadirs during the diagnostic PSG with those obtained during the chinstrap portion of the modified split study and on the optimal CPAP pressure. Non-parametrical statistical methods were used throughout. Data are presented as median; interquartile range (IQR).

RESULTS: There was no statistically significant difference between the diagnostic AHI (16.0/hour; 9.8 to 26.0/hour) and the chinstrap AHI (22.4/ hour; 10.8 to 40.3/hour). However, there was a statistically significant difference between the diagnostic AHI and the optimal CPAP AHI (2.3/ hour; 1.0 to 5.2/ hour) (p<0.001). There was no statistically significant difference between the diagnostic oxygen saturation nadir (84.5%; 80.0 to 88.0%) and the chinstrap oxygen saturation nadir (87.0; 84.0 to 89.0%). However, there was a statistically significant difference between the diagnostic oxygen saturation nadir and the optimal CPAP oxygen saturation nadir (93.0%; 91.0 to 94.3%)(p<0.001).

CONCLUSIONS: A chinstrap alone does not produce statistically significant improvements in AHI and oxygen saturation nadirs in patients with OSA, and is not an effective alternative to CPAP therapy.

CLINICAL IMPLICATIONS: The use of a chin strap alone should not be offered to patients for the treatment of OSA. CPAP remains the gold standard for treatment.

DISCLOSURE: The following authors have nothing to disclose: Neola Gushway-Henry, Sushanth Bhat, Sandeep Riar, Vincent DeBari, Disha Patel, Justin Pi, Liudmila Lysenko, Divya Gupta, Sudhansu Chokroverty, Peter Polos

No Product/Research Disclosure Information


Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
Did Napoleon suffer from chronic rhonchopathy? Acta Otolaryngol Published online Nov 9, 2016;
Guidelines
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543